mhurhangee/patent-ind-claim-en huggingface dataset:
A host T-cell comprising a vector comprising A) a nucleic acid construct encoding a chimeric protein comprising: (i) an extracellular domain of CD4, or a fragment thereof, wherein the fragment binds specifically to gp120, (ii) a transmembrane domain, and (iii) a cytoplasmic domain comprising a) the cytoplasmic domain of the CD3 zeta chain, or a fragment thereof, wherein the fragment modulates activation of T cells, and b) the cytoplasmic domain of CD28, or a fragment thereof, wherein the fragment modulates activation of T cells, wherein the chimeric protein is capable of forming a homodimer when expressed in a T cell, B) a nucleic acid construct encoding a first siRNA specific to an HIV gene, wherein the first siRNA is capable of blocking HIV infection, and C) a nucleic acid construct encoding a second siRNA specific to an HIV gene, wherein the second siRNA is capable of suppressing HIV replication. A) a nucleic acid construct encoding a chimeric protein comprising: (i) an extracellular domain of CD4, or a fragment thereof, wherein the fragment binds specifically to gp120, (ii) a transmembrane domain, and (iii) a cytoplasmic domain comprising a) the cytoplasmic domain of the CD3 zeta chain, or a fragment thereof, wherein the fragment modulates activation of T cells, and b) the cytoplasmic domain of CD28, or a fragment thereof, wherein the fragment modulates activation of T cells, wherein the chimeric protein is capable of forming a homodimer when expressed in a T cell, (i) an extracellular domain of CD4, or a fragment thereof, wherein the fragment binds specifically to gp120, (ii) a transmembrane domain, and (iii) a cytoplasmic domain comprising a) the cytoplasmic domain of the CD3 zeta chain, or a fragment thereof, wherein the fragment modulates activation of T cells, and b) the cytoplasmic domain of CD28, or a fragment thereof, wherein the fragment modulates activation of T cells, wherein the chimeric protein is capable of forming a homodimer when expressed in a T cell, a) the cytoplasmic domain of the CD3 zeta chain, or a fragment thereof, wherein the fragment modulates activation of T cells, and b) the cytoplasmic domain of CD28, or a fragment thereof, wherein the fragment modulates activation of T cells, wherein the chimeric protein is capable of forming a homodimer when expressed in a T cell, B) a nucleic acid construct encoding a first siRNA specific to an HIV gene, wherein the first siRNA is capable of blocking HIV infection, and C) a nucleic acid construct encoding a second siRNA specific to an HIV gene, wherein the second siRNA is capable of suppressing HIV replication.
A differential assembly comprising: a differential case defining first and second output shaft openings that are coaxially aligned along an axis of rotation of the differential case; a first side gear rotatably mounted within the differential case and having a first outer diameter ; a second side gear rotatably mounted within the differential case and having a second outer diameter ; a first pinion gear rotatably coupled to a first pinion gear shaft fixed to the differential case , the first pinion gear meshed for rotation with the first side gear during a first meshing event, the first pinion gear being the only gear coupled to the first pinion gear shaft, and the first pinion gear meshing with the first side gear and not the second side gear; and a second pinion gear rotatably coupled to a second pinion gear shaft fixed to the differential case , the second pinion gear meshed for rotation with the second side gear during a second meshing event, the second pinion gear being the only gear coupled to the second pinion gear shaft, and the second pinion gear meshing with the second side gear and not the first side gear; wherein the first and second pinion gears form a torque transfer arrangement configured for transferring torque between the first and second pinion gears and the first and second side gears to rotate the first and second side gears about the axis of rotation ; wherein the first and second outer diameters are distinct such that the first and second meshing events are offset in time. a differential case defining first and second output shaft openings that are coaxially aligned along an axis of rotation of the differential case; a first side gear rotatably mounted within the differential case and having a first outer diameter ; a second side gear rotatably mounted within the differential case and having a second outer diameter ; a first pinion gear rotatably coupled to a first pinion gear shaft fixed to the differential case , the first pinion gear meshed for rotation with the first side gear during a first meshing event, the first pinion gear being the only gear coupled to the first pinion gear shaft, and the first pinion gear meshing with the first side gear and not the second side gear; and a second pinion gear rotatably coupled to a second pinion gear shaft fixed to the differential case , the second pinion gear meshed for rotation with the second side gear during a second meshing event, the second pinion gear being the only gear coupled to the second pinion gear shaft, and the second pinion gear meshing with the second side gear and not the first side gear; wherein the first and second pinion gears form a torque transfer arrangement configured for transferring torque between the first and second pinion gears and the first and second side gears to rotate the first and second side gears about the axis of rotation ; wherein the first and second outer diameters are distinct such that the first and second meshing events are offset in time.
A texture processor comprising: a texture cache adapted to store textures; a controller configured to read a texture from among stored textures based on a texture request; a format converter configured to convert the read texture into a converted texture having a different format from the read texture, based on a degree of texture precision required by a graphics processing unit, GPU; and a texture filter configured to perform texture filtering using the converted texture, and characterized in that the format converter is configured to determine the degree of texture precision required by the GPU based on at least one of a texture filtering mode and a type of an application programming interface, API, used in the GPU, determine an output format of the converted texture based on a degree of texture precision required by the GPU, and output the converted texture in the determined output format. a texture cache adapted to store textures; a controller configured to read a texture from among stored textures based on a texture request; a format converter configured to convert the read texture into a converted texture having a different format from the read texture, based on a degree of texture precision required by a graphics processing unit, GPU; and a texture filter configured to perform texture filtering using the converted texture,
A method for distributing on-board electrical power in an aircraft comprising a passenger cabin and a primary distribution of electrical power to secondary networks for distributing electrical power to airplane systems, the primary distribution being coupled to the generation of electrical power by the engine(s) of the aircraft, this method comprises the steps of forming a segregating and protecting power-distribution interface between the primary distribution and the secondary network for distributing electrical power of the cabin system, which network is called the cabin network, by an electrical isolation with respect to perturbations acting on the primary distribution, of controlling the extraction of electrical power from the primary distribution via a cabin management depending on the availability of electrical power in this primary distribution, of converting and distributing this available electrical power to the cabin network depending on a suitable configuration of the loads of this cabin network, which configuration is defined depending on an electrical categorization by single-/three-phase AC or DC, and by voltage and frequency level.
A system , comprising: signal acquisition circuitry , which is configured to receive multiple intra-cardiac signals acquired by multiple electrodes of an intra-cardiac probe in a heart of a patient; and a processor , which is configured to: extract multiple local activation time (LAT) values from the intra-cardiac signals; estimate the respective intra-cardiac locations of the electrodes based on signals received from a tracking system; select a group of the intra-cardiac signals; correct one or more of the LAT values in a given intra-cardiac signal, acquired by a given electrode in the group, for expected changes in value due to different spatial positions of the electrodes by applying theoretical differences in the LAT values based on an assumed wave travel speed through the heart; identify in the group one or more LAT values that are statistically deviant in the group by more than a predefined measure of deviation; and visualize the LAT values to a user, excluding the statistically deviant LAT values. signal acquisition circuitry , which is configured to receive multiple intra-cardiac signals acquired by multiple electrodes of an intra-cardiac probe in a heart of a patient; and a processor , which is configured to: extract multiple local activation time (LAT) values from the intra-cardiac signals; estimate the respective intra-cardiac locations of the electrodes based on signals received from a tracking system; select a group of the intra-cardiac signals; correct one or more of the LAT values in a given intra-cardiac signal, acquired by a given electrode in the group, for expected changes in value due to different spatial positions of the electrodes by applying theoretical differences in the LAT values based on an assumed wave travel speed through the heart; identify in the group one or more LAT values that are statistically deviant in the group by more than a predefined measure of deviation; and visualize the LAT values to a user, excluding the statistically deviant LAT values. extract multiple local activation time (LAT) values from the intra-cardiac signals; estimate the respective intra-cardiac locations of the electrodes based on signals received from a tracking system; select a group of the intra-cardiac signals; correct one or more of the LAT values in a given intra-cardiac signal, acquired by a given electrode in the group, for expected changes in value due to different spatial positions of the electrodes by applying theoretical differences in the LAT values based on an assumed wave travel speed through the heart; identify in the group one or more LAT values that are statistically deviant in the group by more than a predefined measure of deviation; and visualize the LAT values to a user, excluding the statistically deviant LAT values.
A combine harvester comprising a chassis , rear wheels at the back of the harvester, and pivotable ground engaging means which are pivotable with respect to the chassis about an axis that is transversal to the longitudinal direction of the harvester, the axis lying between a front and rear portion of the ground engaging means so that the front and rear portions may be tilted up or down by pivoting of the ground engaging means, characterised in that the harvester further comprises, for each of the pivotable ground engaging means, a variable length actuator mounted between the chassis and the ground engaging means, the actuator being configured to actuate upward and/or downward tilting of the front portion of the ground engaging means to thereby counteract excessive tilting of the ground engaging means and prevent the ground engaging means from burrowing into the terrain, wherein the actuators are integrated in a lifting and/or levelling system, configured to lift up the entire chassis or at least a front portion of the chassis over a given distance relative to the ground engaging means.
A superabsorbent polymers (SAP) evaluation apparatus comprising: a main body installed with a lifting bar that is configured to be raised or lowered; a container portion installed under the lifting bar in the main body , comprising an internal containing space configured to contain an absorber ; an operating portion connected to the lifting bar , comprising: a lifting plate that is configured to be raised or lowered within the internal containing space and to apply pressure to the absorber ; and an injection portion configured to inject an ink in a direction of the absorber ; a dispersion measurement portion for measuring dispersion of the ink through the absorber ; and a controller installed at the main body configured to measure absorption of the ink into the absorber and to measure a swelling capacity of the absorber while the ink is injected into the absorber ; wherein the operating portion comprises: an injection body of which a first side is connected to an end of the lifting bar , comprising the injection portion formed integrally therein; and a lifting plate connected to a second side of the injection body , with a bottom thereof making contact with the absorber ; and the dispersion measurement portion comprises a camera configured to capture how the ink is dispersed into the absorber . a main body installed with a lifting bar that is configured to be raised or lowered; a container portion installed under the lifting bar in the main body , comprising an internal containing space configured to contain an absorber ; an operating portion connected to the lifting bar , comprising: a lifting plate that is configured to be raised or lowered within the internal containing space and to apply pressure to the absorber ; and an injection portion configured to inject an ink in a direction of the absorber ; a dispersion measurement portion for measuring dispersion of the ink through the absorber ; and a controller installed at the main body configured to measure absorption of the ink into the absorber and to measure a swelling capacity of the absorber while the ink is injected into the absorber ; wherein the operating portion comprises: an injection body of which a first side is connected to an end of the lifting bar , comprising the injection portion formed integrally therein; and a lifting plate connected to a second side of the injection body , with a bottom thereof making contact with the absorber ; and the dispersion measurement portion comprises a camera configured to capture how the ink is dispersed into the absorber . an injection body of which a first side is connected to an end of the lifting bar , comprising the injection portion formed integrally therein; and a lifting plate connected to a second side of the injection body , with a bottom thereof making contact with the absorber ; and the dispersion measurement portion comprises a camera configured to capture how the ink is dispersed into the absorber .
A method of harvesting crops using a carriage provided with a harvesting device, the method comprising the sequential steps of: a) harvesting plural crops using the harvesting device; b) measuring or estimating the ground height at each harvested crop in order to generate baseline ground data, wherein the generated baseline ground data comprises average ground height data and/or variations in ground height; c) determining a height of a subsequent crop to determine a desired harvest height; and d) comparing the baseline ground data to the desired harvest height to decide whether to harvest the subsequent crop. a) harvesting plural crops using the harvesting device; b) measuring or estimating the ground height at each harvested crop in order to generate baseline ground data, wherein the generated baseline ground data comprises average ground height data and/or variations in ground height; c) determining a height of a subsequent crop to determine a desired harvest height; and d) comparing the baseline ground data to the desired harvest height to decide whether to harvest the subsequent crop.
A drug delivery device comprising: a housing ; a syringe assembly comprising a barrel , a stopper , and a cannula , at least a portion of the syringe assembly positioned within the housing (26, 28 46); a drive assembly configured to move the stopper within the barrel upon actuation of the drive assembly , at least a portion of the drive assembly positioned within the housing ; a needle cover having a pre-use position where the cannula is positioned within the needle cover , an actuation position where the needle cover is configured to actuate the drive assembly , and a post-use position where the cannula is positioned within the needle cover ; a cap receiving a portion of the needle cover , the cap comprising a protrusion received by a cap opening defined by the needle cover and configured to prevent movement of the needle cover from the pre-use position to the actuation position; and a lever actuation member moveable between a locked position where actuation of the drive assembly is prevented and a released position where actuation of the drive assembly is allowed, the needle cover engaging the lever actuation member and moving the lever actuation member to the released position when the needle cover is moved in the actuation position, characterized in that the lever actuation member is rotatable about a rotation axis between the locked position and the released position, the rotation axis extending perpendicular to the longitudinal axis of the drug delivery device . a housing ; a syringe assembly comprising a barrel , a stopper , and a cannula , at least a portion of the syringe assembly positioned within the housing (26, 28 46); a drive assembly configured to move the stopper within the barrel upon actuation of the drive assembly , at least a portion of the drive assembly positioned within the housing ; a needle cover having a pre-use position where the cannula is positioned within the needle cover , an actuation position where the needle cover is configured to actuate the drive assembly , and a post-use position where the cannula is positioned within the needle cover ; a cap receiving a portion of the needle cover , the cap comprising a protrusion received by a cap opening defined by the needle cover and configured to prevent movement of the needle cover from the pre-use position to the actuation position; and a lever actuation member moveable between a locked position where actuation of the drive assembly is prevented and a released position where actuation of the drive assembly is allowed, the needle cover engaging the lever actuation member and moving the lever actuation member to the released position when the needle cover is moved in the actuation position, characterized in that the lever actuation member is rotatable about a rotation axis between the locked position and the released position, the rotation axis extending perpendicular to the longitudinal axis of the drug delivery device .
A method for slowing down an aircraft having a propeller and propeller blades , the method comprising: operating the propeller at a reference speed with the propeller blades in a first position; applying a load to the propeller to slow down a rotational speed of the propeller when the propeller is in a windmilling state or just before the propeller enters the windmilling state; adjusting the propeller blades to a second position in response to the load being applied, to increase the rotational speed of the propeller back towards the reference speed; and operating the propeller at the reference speed with the propeller blades in the second position. operating the propeller at a reference speed with the propeller blades in a first position; applying a load to the propeller to slow down a rotational speed of the propeller when the propeller is in a windmilling state or just before the propeller enters the windmilling state; adjusting the propeller blades to a second position in response to the load being applied, to increase the rotational speed of the propeller back towards the reference speed; and operating the propeller at the reference speed with the propeller blades in the second position.
An electrode for a lithium secondary battery, which comprises an electrode active material, an aqueous binder, and either: a compound represented by the following Formula 1 and a compound represented by the following Formula 2 or a compound represented by the following Formula 3 in which the compound represented by Formula 1 and the compound represented by Formula 2 are chemically combined: wherein, in Formula 1, 2, and 3, R 1 to R 3 are each independently selected from the group consisting of an alkoxy group having 1 to 3 carbon atoms, and R 4 is one selected from the group consisting of N(R 7 ) 2 , CO 2 R 7 , R 8 SH and R 8 Si(OR 7 ) 3 , R 5 is hydrogen, R 6 to R 7 are each independently hydrogen or an alkyl group having 1 to 3 carbon atoms, R 8 is an alkylene group having 1 to 3 carbon atoms, and n is an integer selected from 1 to 6, wherein one compound selected from the group consisting of the compound represented by Formula 1, the compound represented by Formula 2 and combinations thereof is a cross-linker which crosslinks the aqueous binder and wherein the cross-linker is included in the amount of 0.1 to 20% by weight based on a total weight of the electrode. a compound represented by the following Formula 1 and a compound represented by the following Formula 2 or a compound represented by the following Formula 3 in which the compound represented by Formula 1 and the compound represented by Formula 2 are chemically combined: R 1 to R 3 are each independently selected from the group consisting of an alkoxy group having 1 to 3 carbon atoms, and R 4 is one selected from the group consisting of N(R 7 ) 2 , CO 2 R 7 , R 8 SH and R 8 Si(OR 7 ) 3 , R 5 is hydrogen, R 6 to R 7 are each independently hydrogen or an alkyl group having 1 to 3 carbon atoms, R 8 is an alkylene group having 1 to 3 carbon atoms, and n is an integer selected from 1 to 6, wherein one compound selected from the group consisting of the compound represented by Formula 1, the compound represented by Formula 2 and combinations thereof is a cross-linker which crosslinks the aqueous binder and wherein the cross-linker is included in the amount of 0.1 to 20% by weight based on a total weight of the electrode.
A compound of Formula : or a pharmaceutically acceptable salt or any individual isomer thereof, wherein either R 1 is -(CH 2 ) n R 3 where n is 1, 2 or 3 and R 3 is selected from OH, NH 2 or NHC(O)NH 2 and R 2 is or R 2 is -(CH 2 ) n R 3 where n is 1, 2 or 3 and R 3 is selected from OH, NH 2 or NHC(O)NH 2 and R 1 is X is CH 2 or NHCO and CM represents a chelator moiety, optionally containing a chelated nonradioactive or radioactive cation and the fluorine atom is optionally 18 F. or a pharmaceutically acceptable salt or any individual isomer thereof, wherein either R 1 is -(CH 2 ) n R 3 where n is 1, 2 or 3 and R 3 is selected from OH, NH 2 or NHC(O)NH 2 and R 2 is or R 2 is -(CH 2 ) n R 3 where n is 1, 2 or 3 and R 3 is selected from OH, NH 2 or NHC(O)NH 2 and R 1 is X is CH 2 or NHCO and CM represents a chelator moiety, optionally containing a chelated nonradioactive or radioactive cation and the fluorine atom is optionally 18 F.